2012
$150M
from 17 investors over 17 rounds
Akeso Biopharma, Inc. raised $150M on November 4, 2019
Investors: Lake Bleu Capital (Hong Kong) Limited, OrbiMed Advisors, 建信资本管理有限责任公司, Loyal Valley Capital, BOCOM International, K. Wah Group, Shenzhen Capital Group Co., Ltd, Sino Biopharmaceutical Limited and 深圳前海勤智国际资本管理有限公司
Akeso Biopharma, Inc. raised $4.1M on October 30, 2018
Investors: 建信资本管理有限责任公司, Shenzhen Capital Group Co., Ltd and 深圳前海勤智国际资本管理有限公司
Akeso Biopharma, Inc. raised $45M on August 29, 2017
Investors: 深圳前海勤智国际资本管理有限公司, QianHai FoFs and Shenzhen Capital Group Co., Ltd
Akeso Biopharma, Inc. raised $20M on November 19, 2015
Investors: 建信资本管理有限责任公司 and Shenzhen Capital Group Co., Ltd